PRECISION AQ
Live / Registered — Registered (as of 10 Mar 2026)
What this means for you
Registered since 10 Mar 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98474530
- Registration number
- 8170568
- Mark type
- Stylized text
- Filed
- 29 Mar 2024
- Published for opposition
- 03 Dec 2024
- Registered
- 10 Mar 2026
- Attorney of record
- Donna H. Hartman
Goods and services
- Class 035 — Advertising and business services: Business management consulting services to the pharmaceutical and life sciences companies to provide advice and business strategies to conduct and manage research and clinical development of targeted therapies and diagnostics, clinical solutions, regulatory guidance, health economics design, launch planning, access strategy, promotional effectiveness, and market adoption; Business management consultation in the field of promotion opportunity assessment, promotion effectiveness, payer promotion strategy, account manager and sales force promotion strategy and distribution strategy; Business and management consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, and nutrition; public policy consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, and nutrition; public policy consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, and nutrition; Business services provided to the healthcare industry, namely, the creation, collection, analysis, and reporting of health care data and information for support of business and public policy decision-making; Provision of statistical and commercial and business information in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, and nutrition; Public relations and public relations consultancy; Provision of statistical information in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, and nutrition; Compiling and analyzing statistics, data, and other sources of information for financial and business purposes in the healthcare, pharmaceuticals, biotechnology, medical devices, and nutrition; Business services, namely, providing investor relation consulting services, matching potential investors with entrepreneurs and entities seeking investors.
- Class 041 — Education and entertainment services: Providing non-downloadable electronic publications in the nature of informational reports for support of business and policy decisions in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, and nutrition.
- Class 042 — Scientific and technological services: Scientific consulting services in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, and nutrition; Provision of scientific research information in the fields of healthcare, pharmaceuticals, biotechnology, medical devices, and nutrition; Providing medical and scientific research information in the field of clinical trials as they relate to healthcare, pharmaceuticals, biotechnology, medical devices, and nutrition.
Owner
- Precision Medicine Group, LLC, Bethesda, MD, US
- Precision Medicine Group, LLC, Bethesda, MD, US
- Precision Medicine Group, LLC, Bethesda, MD, US
Prosecution history
- 10 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
- 16 Feb 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 Feb 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Jan 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Jul 2025 — USE AMENDMENT FILED
- 18 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Jul 2025 — TEAS STATEMENT OF USE RECEIVED
- 14 Jan 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Dec 2024 — PUBLISHED FOR OPPOSITION
- 27 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Oct 2024 — EXAMINER'S AMENDMENT ENTERED
- 15 Oct 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED